Counsell, John R.
Asgarian, Zeinab
Meng, Jinhong
Ferrer, Veronica
Vink, Conrad A.
Howe, Steven J.
Waddington, Simon N.
Thrasher, Adrian J.
Muntoni, Francesco
Morgan, Jennifer E.
Danos, Olivier
Article History
Received: 5 March 2016
Accepted: 13 February 2017
First Online: 17 March 2017
Change Date: 29 August 2017
Change Type: Update
Change Details: A correction has been published and is appended to both the HTML and PDF versions of this paper. The error has been fixed in the paper.
Change Date: 29 August 2017
Change Type: Erratum
Change Details: Scientific Reports 7: Article number: 44775; published online: 17 March 2017; updated: 29 August 2017. This article was published twice in error during a change in production systems. The publisher apologizes to the authors and readers for the error. When citing this work, please refer to the original version.
Competing interests
: F.M. has served on scientific advisory boards for PTC Therapeutics, Servier, Summit, Akashi, Pfizer and Sarepta Therapeutics. His institution receives research support for clinical trials from Biomarin, PTC Therapeutics, Pfizer, Sarepta Therapeutics and Summit. A.J.T. is a founder and advisor to Orchard therapeutics. The other authors declare no competing financial interests.